Additional Titles & Roles
- Professor of Neurology, of Radiology, and of Neuroscience
Education & Training
- Fellowship, Movement Disorders and Neuroimaging: Washington University, St. Louis, MO, 1996
- Residency: Washington University, St. Louis, MO, 1994
- MD: Duke University, Durham, NC, 1990
- BS, Mathematics: Brigham Young University, Provo, UT, 1986
Major Awards
- Certification in Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (UCNS), 2006, 2006
- member, NIMH Motor Systems Domain RDoC workshop, 2016
- Named a Fellow of CINP, the International College of Neuropsychopharmacology, 2015
- Named a Fellow of the American Neuropsychiatric Association, 2006
- Hope Award from the St. Louis chapter of the HDSA (Huntington Disease Society of America), 2006
- American College of Neuropsychopharmacology (ACNP) / Bristol-Myers Squibb Travel Award, 2001
Areas of Clinical Interest
Tourette syndrome (TS) and other tic disorders, neuropsychiatry of Parkinson’s disease and dystonia, Huntington’s disease, tardive dyskinesia, catatonia, functional or atypical movement disorders
Research Interests
Tourette syndrome (TS) and other tic disorders.
Neuroimaging and clinical studies of TS and other movement disorders.
Neuroimaging methods development including pharmacological fMRI.
Key Publications
- Grossen SC, Arbuckle AL, Bihun EC, Koller JM, Song DY, Reiersen AM, Schlaggar BL, Greene DJ, Black KJ (2024 Oct [online ahead of print]). We’ve all been wrong about provisional tic disorder. Compr Psychiatry. 134: 152510.
Read publication »We’ve all been wrong about provisional tic disorder. - Iverson AM, Arbuckle AL, Ueda K, Song DY, Bihun EC, Koller JM, Wallendorf M, Black KJ, (2023 Mar). Median nerve stimulation for treatment of tics: Randomized, controlled, crossover trial J Clin Med. 12(7): 2514
Read publication »Median Nerve Stimulation for Treatment of Tics: Randomized, Controlled, Crossover Trial. - Black KJ, Acevedo HK, Koller JM (2020 May 6). Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease. PubMed PMID 32477245 PubMedCentral PMCID: PMC7232584 DOI: 10.3389/fneur.2020.00370
Read publication »Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease. - *Greene DJ, *Williams AC III, Koller JM, Schlaggar BL, Black KJ, The Tourette Association of America Neuroimaging Consortium (2016). Brain structure in pediatric Tourette syndrome. Mol Psychiatry. 22(7): 972-80. PubMed PMID: 27777415 PubMedCentral PMCID: PMC5405013 DOI: 10.1038/mp.2016.194
*Equal contributors
Read publication »Brain structure in pediatric Tourette syndrome. - Eisenstein SA, Koller JM, Black KD, Campbell MC, Lugar HM, Ushe M, Tabbal SD, Karimi M, Hershey T, Perlmutter JS, Black KJ (2014 Aug). Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Ann Neurol. 76(2): 279-95. PubMed PMID 24953991 PubMedCentral PMCID: PMC4172323 DOI: 10.1002/ana.24204
Read publication »Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. - Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI (2010 Dec 1). Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. J Neurosci. 30(48): 16284-92. PubMed PMID 21123574 PubMedCentral PMCID: PMC3008651 DOI: 10.1523/JNEUROSCI.2590-10.2010
Read publication »Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease.
Funded Research Projects
NIMH(Significant Contributor): Tourette Syndrome genetics and neuroimaging international collaborative study
NIDDK(Significant Contributor): Brain health across the metabolic continuum in youth at risk for T2D
NIMH(Significant Contributor):Longitudinal Study of Brain Imaging and Cognitive Markers of Tourette Syndrome in Children
Emalex Biosciences(site PI):A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults with Tourette’s Disorder (EBS101-TD319)